Synopsis
Synopsis
0
JDMF
0
KDMF
0
VMF
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Catapres
2. Catapresan
3. Catapressan
4. Chlophazolin
5. Clofelin
6. Clofenil
7. Clonidine
8. Clonidine Dihydrochloride
9. Clonidine Monohydrobromide
10. Clonidine Monohydrochloride
11. Clopheline
12. Dihydrochloride, Clonidine
13. Dixarit
14. Gemiton
15. Hemiton
16. Hydrochloride, Clonidine
17. Isoglaucon
18. Klofelin
19. Klofenil
20. M 5041t
21. M-5041t
22. M5041t
23. Monohydrobromide, Clonidine
24. Monohydrochloride, Clonidine
25. St 155
26. St-155
27. St155
1. 4205-91-8
2. Clonidine Hcl
3. 2-(2,6-dichloroanilino)-2-imidazoline Hydrochloride
4. Kapvay
5. N-(2,6-dichlorophenyl)-4,5-dihydro-1h-imidazol-2-amine Hydrochloride
6. St-155
7. Catapresan
8. Jenloga
9. Clonidine (hydrochloride)
10. Nsc-756699
11. 2-(2,6-dichlorophenylamino)-2-imidazoline Hydrochloride
12. W76i6xxf06
13. Dichloranilino Imidazolin
14. 2-((2,6-dichlorophenyl)imino)imidazolidine Monohydrochloride
15. Benzenamine, 2,6-dichloro-n-2-imidazolidinylidene-, Monohydrochloride
16. Chlophazolin
17. Dispaclonidin
18. Normopresan
19. Atensina
20. Barclyd
21. Capresin
22. Caprysin
23. Catanidin
24. Clofelin
25. Clonilou
26. Clonisin
27. Clonistada
28. Dixarit
29. Edolglau
30. Glausine
31. Haemiton
32. Ipotensium
33. Isoglaucon
34. Katapresan
35. Klophelin
36. Iporel
37. 1h-imidazol-2-amine, N-(2,6-dichlorophenyl)-4,5-dihydro- [cas]
38. Apo-clonidine
39. Clonidil-riker
40. Novo-clonidine
41. Clonid-ophal
42. Nu-clonidine
43. N-(2,6-dichlorophenyl)-4,5-dihydro-1h-imidazol-2-amine Hcl
44. 1h-imidazol-2-amine, N-(2,6-dichlorophenyl)-4,5-dihydro-, Monohydrochloride (9ci)
45. 2-[(2,6-dichlorophenyl)amino-2-imidazoline Hydrochloride
46. Bapresan
47. Clonicel
48. Trialox
49. Clonidine Monohydrochloride
50. Smr000466276
51. 205c918
52. Sr-01000075246
53. Einecs 224-121-5
54. Cas-4205-91-8
55. Mfcd00036705
56. N-(2,6-dichlorophenyl)imidazolidin-2-imine;hydrochloride
57. Unii-w76i6xxf06
58. Clonidine-hcl
59. Sr-01000759380
60. Prestwick_73
61. Catapres (tn)
62. 4,5-dihydro-
63. 2-((2,6-dichlorophenyl)amino)-2-imidazoline Hydrochloride
64. 2-imidazoline, 2-(2,6-dichloroanilino)-, Monohydrochloride
65. 2-(2,6-dichlorophenylamino)-2-imidazolin Hydrochlorid [german]
66. Benzenamine, 2,6-dichloro-n-2-imidazolidinylidene-, Hydrochloride
67. Clonidine Hydrochloride [usan:usp:ban:jan]
68. 1h-imidazol-2-amine, N-(2,6-dichlorophenyl)-4,5-dihydro-, Monohydrochloride
69. Clonidinehydrochloride
70. N-(2,6-dichlorophenyl)-
71. Chembl1705
72. Clonidine Hydrochloride,(s)
73. Dsstox_cid_24670
74. Dsstox_rid_80388
75. Dsstox_gsid_44670
76. Schembl40751
77. Mls000758256
78. Mls001424222
79. Clonidine Hydrochloride, Solid
80. 2-(2,6-dichlorophenylamino)-2-imidazolin Hydrochlorid
81. Chebi:3758
82. Dtxsid8044670
83. Hy-b0409a
84. Clonidine Hydrochloride (catapres)
85. Hms1568b18
86. Hms3414h03
87. Hms3678h03
88. Pharmakon1600-01500198
89. Bcp14375
90. Clonidine Hydrochloride [mi]
91. Tox21_301552
92. Tox21_500268
93. Bdbm50020341
94. Ccg-40087
95. Clonidine Hydrochloride (jp17/usp)
96. Clonidine Hydrochloride [jan]
97. N-(2,6-dichlorophenyl)-4,5-dihydro-1h-imidazol-2-amine;hydrochloride
98. Nsc756699
99. S2458
100. Clonidine Hydrochloride [usan]
101. Akos005267207
102. Akos024458609
103. Akos028114993
104. Ccg-101051
105. Ccg-212540
106. Ccg-229466
107. Clonidine Hydrochloride [mart.]
108. Clonidine Hydrochloride [vandf]
109. Ks-1253
110. Lp00268
111. Nc00301
112. Nsc 756699
113. Clonidine Hydrochloride [usp-rs]
114. Clonidine Hydrochloride [who-dd]
115. Ncgc00093726-01
116. Ncgc00093726-02
117. Ncgc00180902-01
118. Ncgc00256172-01
119. Ncgc00260953-01
120. Ac-10306
121. Ac-29742
122. Clonidine Hydrochloride, >=98.0% (tlc)
123. Clonidine Hydrochloride [ep Impurity]
124. Clonidine Hydrochloride [orange Book]
125. D1353
126. Eu-0100268
127. Ft-0601096
128. Ft-0665123
129. Sw197681-3
130. Clonidine Hydrochloride [ep Monograph]
131. C 7897
132. Clonidine Hydrochloride [usp Monograph]
133. D00604
134. D81843
135. Clorpres Component Clonidine Hydrochloride
136. A825736
137. Clonidine Hydrochloride 100 Microg/ml In Methanol
138. Combipres Component Clonidine Hydrochloride
139. Clonidine Hydrochloride Component Of Clorpres
140. Q-200880
141. Sr-01000075246-1
142. Sr-01000075246-3
143. Sr-01000759380-5
144. Clonidine Hydrochloride (catapres) [largely Precursor]
145. Clonidine Hydrochloride Component Of Combipres
146. Q27292429
147. 2-[(2,6-dichlorophenyl)imino]imidazolidine Hydrochloride
148. Clonidine Hydrochloride 1.0 Mg/ml In Methanol (as Free Base)
149. Clonidine Hydrochloride, British Pharmacopoeia (bp) Reference Standard
150. Clonidine Hydrochloride, European Pharmacopoeia (ep) Reference Standard
151. Clonidine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
152. 1h-imidazol-2-amine, N-(2,6-dichlorophenyl)-4,5-dihydro-, Hydrochloride (1:1)
153. N-[2,6-bis(chloranyl)phenyl]-4,5-dihydro-1h-imidazol-2-amine Hydrochloride
Molecular Weight | 266.6 g/mol |
---|---|
Molecular Formula | C9H10Cl3N3 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 1 |
Rotatable Bond Count | 2 |
Exact Mass | 264.994030 g/mol |
Monoisotopic Mass | 264.994030 g/mol |
Topological Polar Surface Area | 36.4 Ų |
Heavy Atom Count | 15 |
Formal Charge | 0 |
Complexity | 222 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Clonidine hydrochloride |
PubMed Health | Clonidine |
Drug Classes | Analgesic, Anesthetic Adjunct, Antihypertensive, Antimigraine, Cardiovascular Agent, Central Nervous System Agent, Diagnostic Agent, Pheochromocytoma |
Drug Label | Clonidine hydrochloride, USP is a centrally acting alpha-agonist hypotensive agent available as tablets for oral administration in three dosage strengths: 0.1 mg, 0.2 mg, and 0.3 mg. The 0.1 mg tablet is equivalent to 0.087 mg of the free base.The fo... |
Active Ingredient | Clonidine hydrochloride |
Dosage Form | Tablet, extended release; Injectable; Tablet |
Route | Injection; Oral |
Strength | 0.2mg; 1mg/10ml (0.1mg/ml); 0.3mg; 5mg/10ml (0.5mg/ml); 0.1mg |
Market Status | Prescription |
Company | Exela Pharma Scs; Anchen Pharms; Actavis Elizabeth; Fresenius Kabi Usa; Unichem; Mutual Pharm; Vintage; Alembic Pharms; Hikma Farmaceutica; Luitpold; Sun Pharm Inds; Zydus Pharms Usa; Carlsbad; Mylan; Impax Labs; Dava Pharms |
2 of 4 | |
---|---|
Drug Name | Kapvay |
Drug Label | KAPVAY (clonidine hydrochloride) extended-release is a centrally acting alpha2-adrenergic agonist available as 0.1 mg or 0.2 mg extended-release tablets for oral administration. Each 0.1 mg and 0.2 mg tablet is equivalent to 0.087 mg and 0.174 mg, re... |
Active Ingredient | Clonidine hydrochloride |
Dosage Form | Tablet, extended release |
Route | Oral |
Strength | 0.1mg; 0.2mg |
Market Status | Prescription |
Company | Concordia Pharms |
3 of 4 | |
---|---|
Drug Name | Clonidine hydrochloride |
PubMed Health | Clonidine |
Drug Classes | Analgesic, Anesthetic Adjunct, Antihypertensive, Antimigraine, Cardiovascular Agent, Central Nervous System Agent, Diagnostic Agent, Pheochromocytoma |
Drug Label | Clonidine hydrochloride, USP is a centrally acting alpha-agonist hypotensive agent available as tablets for oral administration in three dosage strengths: 0.1 mg, 0.2 mg, and 0.3 mg. The 0.1 mg tablet is equivalent to 0.087 mg of the free base.The fo... |
Active Ingredient | Clonidine hydrochloride |
Dosage Form | Tablet, extended release; Injectable; Tablet |
Route | Injection; Oral |
Strength | 0.2mg; 1mg/10ml (0.1mg/ml); 0.3mg; 5mg/10ml (0.5mg/ml); 0.1mg |
Market Status | Prescription |
Company | Exela Pharma Scs; Anchen Pharms; Actavis Elizabeth; Fresenius Kabi Usa; Unichem; Mutual Pharm; Vintage; Alembic Pharms; Hikma Farmaceutica; Luitpold; Sun Pharm Inds; Zydus Pharms Usa; Carlsbad; Mylan; Impax Labs; Dava Pharms |
4 of 4 | |
---|---|
Drug Name | Kapvay |
Drug Label | KAPVAY (clonidine hydrochloride) extended-release is a centrally acting alpha2-adrenergic agonist available as 0.1 mg or 0.2 mg extended-release tablets for oral administration. Each 0.1 mg and 0.2 mg tablet is equivalent to 0.087 mg and 0.174 mg, re... |
Active Ingredient | Clonidine hydrochloride |
Dosage Form | Tablet, extended release |
Route | Oral |
Strength | 0.1mg; 0.2mg |
Market Status | Prescription |
Company | Concordia Pharms |
Sedation
Adrenergic alpha-2 Receptor Agonists
Compounds that bind to and activate ADRENERGIC ALPHA-2 RECEPTORS. (See all compounds classified as Adrenergic alpha-2 Receptor Agonists.)
Analgesics
Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
Sympatholytics
Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here. (See all compounds classified as Sympatholytics.)
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-01-29
Pay. Date : 2015-01-16
DMF Number : 12964
Submission : 1998-04-27
Status : Active
Type : II
NDC Package Code : 51014-7543
Start Marketing Date : 2009-08-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : ASMF, CA |
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-01-29
Pay. Date : 2015-01-16
DMF Number : 4778
Submission : 1983-01-21
Status : Active
Type : II
Certificate Number : CEP 1998-112 - Rev 04
Issue Date : 2024-02-01
Type : Chemical
Substance Number : 477
Status : Valid
NDC Package Code : 51014-7543
Start Marketing Date : 2009-08-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : ASMF, CA |
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-06-06
Pay. Date : 2019-05-31
DMF Number : 23906
Submission : 2010-06-14
Status : Active
Type : II
NDC Package Code : 52935-0051
Start Marketing Date : 2010-06-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16929
Submission : 2003-10-06
Status : Active
Type : II
Date of Issue : 2022-06-17
Valid Till : 2025-07-21
Written Confirmation Number : WC-0062
Address of the Firm :
NDC Package Code : 53747-010
Start Marketing Date : 2003-10-06
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35599
Submission : 2021-02-19
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6307
Submission : 1986-04-25
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6128
Submission : 1985-11-20
Status : Inactive
Type : II
NDC Package Code : 52935-0051
Start Marketing Date : 2010-06-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6357
Submission : 1986-05-12
Status : Inactive
Type : II
Certificate Number : CEP 2004-072 - Rev 01
Issue Date : 2024-11-07
Type : Chemical
Substance Number : 477
Status : Valid
Date of Issue : 2022-06-30
Valid Till : 2025-07-28
Written Confirmation Number : WC-0063
Address of the Firm :
NDC Package Code : 53747-010
Start Marketing Date : 2003-10-06
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Clonidine Hydrochloride (USP)/Clonidine
Date of Issue : 2019-07-05
Valid Till : 2022-07-02
Written Confirmation Number : WC-0081
Address of the Firm : (API Division Panelav), Panelav, Tal-Halol, Dist-Panchmahal, Gujarat, India
Date of Issue : 2018-12-03
Valid Till : 2021-07-09
Written Confirmation Number : WC-0424
Address of the Firm : Plot no. 61 Additional Ambernath Ambernath East Dist. Thane 421506 Maharashtra
Date of Issue : 2022-06-30
Valid Till : 2025-07-28
Written Confirmation Number : WC-0063
Address of the Firm : Plot No. 99, MIDC Area, Dhatav, Roha, Dist Raigad
Date of Issue : 2022-06-17
Valid Till : 2025-07-21
Written Confirmation Number : WC-0062
Address of the Firm : Plot No.197, Sector 1, Pithampur, Dist. Dhar, M.P
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Menograine Drops
Dosage Form : DRP
Dosage Strength : 25mg / 0.5ml
Packaging : 5X1mg / 0.5ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Menograine
Dosage Form : TAB
Dosage Strength : 25mcg
Packaging : 100X1mcg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Menograine
Dosage Form : TAB
Dosage Strength : 25mcg
Packaging : 30X1mcg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : RX
Registration Country : USA
Brand Name : NEXICLON XR
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 0.17MG BASE
Packaging :
Approval Date : 2009-12-03
Application Number : 22500
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NEXICLON XR
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 0.26MG BASE
Packaging :
Approval Date : 2009-12-03
Application Number : 22500
Regulatory Info : DISCN
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : CLONIDINE
Dosage Form : SYSTEM;TRANSDERMAL
Dosage Strength : 0.1MG/24HR
Packaging :
Approval Date : 2010-08-20
Application Number : 79090
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : CLONIDINE
Dosage Form : SYSTEM;TRANSDERMAL
Dosage Strength : 0.2MG/24HR
Packaging :
Approval Date : 2010-08-20
Application Number : 79090
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : CLONIDINE
Dosage Form : SYSTEM;TRANSDERMAL
Dosage Strength : 0.3MG/24HR
Packaging :
Approval Date : 2010-08-20
Application Number : 79090
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CLONIDINE HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 0.1MG
Packaging :
Approval Date : 2018-04-30
Application Number : 210680
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CLONIDINE HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 0.2MG
Packaging :
Approval Date : 2015-05-15
Application Number : 203320
Regulatory Info : DISCN
Registration Country : USA
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Clonidine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Clonidine, including repackagers and relabelers. The FDA regulates Clonidine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Clonidine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Clonidine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Clonidine supplier is an individual or a company that provides Clonidine active pharmaceutical ingredient (API) or Clonidine finished formulations upon request. The Clonidine suppliers may include Clonidine API manufacturers, exporters, distributors and traders.
click here to find a list of Clonidine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Clonidine DMF (Drug Master File) is a document detailing the whole manufacturing process of Clonidine active pharmaceutical ingredient (API) in detail. Different forms of Clonidine DMFs exist exist since differing nations have different regulations, such as Clonidine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Clonidine DMF submitted to regulatory agencies in the US is known as a USDMF. Clonidine USDMF includes data on Clonidine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Clonidine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Clonidine suppliers with USDMF on PharmaCompass.
A Clonidine CEP of the European Pharmacopoeia monograph is often referred to as a Clonidine Certificate of Suitability (COS). The purpose of a Clonidine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Clonidine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Clonidine to their clients by showing that a Clonidine CEP has been issued for it. The manufacturer submits a Clonidine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Clonidine CEP holder for the record. Additionally, the data presented in the Clonidine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Clonidine DMF.
A Clonidine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Clonidine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Clonidine suppliers with CEP (COS) on PharmaCompass.
A Clonidine written confirmation (Clonidine WC) is an official document issued by a regulatory agency to a Clonidine manufacturer, verifying that the manufacturing facility of a Clonidine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Clonidine APIs or Clonidine finished pharmaceutical products to another nation, regulatory agencies frequently require a Clonidine WC (written confirmation) as part of the regulatory process.
click here to find a list of Clonidine suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Clonidine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Clonidine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Clonidine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Clonidine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Clonidine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Clonidine suppliers with NDC on PharmaCompass.
Clonidine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Clonidine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Clonidine GMP manufacturer or Clonidine GMP API supplier for your needs.
A Clonidine CoA (Certificate of Analysis) is a formal document that attests to Clonidine's compliance with Clonidine specifications and serves as a tool for batch-level quality control.
Clonidine CoA mostly includes findings from lab analyses of a specific batch. For each Clonidine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Clonidine may be tested according to a variety of international standards, such as European Pharmacopoeia (Clonidine EP), Clonidine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Clonidine USP).
LOOKING FOR A SUPPLIER?